Surface-associated serum proteins inhibit the uptake of phosphatidylserine and poly(ethylene glycol) liposomes by mouse macrophages  by Johnstone, Sharon A et al.
Surface-associated serum proteins inhibit the uptake of
phosphatidylserine and poly(ethylene glycol) liposomes by
mouse macrophages
Sharon A. Johnstone *, Dana Masin, Lawrence Mayer, Marcel B. Bally
Division of Medical Oncology ^ Advanced Therapeutics, British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, B.C.,
Canada V5Z 4E6
Received 27 October 2000; received in revised form 18 January 2001; accepted 2 February 2001
Abstract
Serum proteins, acting as opsonins, are believed to contribute significantly to liposome^macrophage cell association and
thus regulate liposome uptake by cells of the mononuclear phagocytic system (MPS). We studied the effect of serum protein
on binding and uptake of phosphatidylglycerol-, phosphatidylserine-, cardiolipin-, and N,N-dioleyl-N,N-dimethylammo-
nium chloride- (DODAC) containing as well as poly(ethylene glycol)- (PEG) containing liposomes by mouse bone marrow
macrophages in vitro. Consistent with the postulated surface-shielding properties of PEG, protein-free uptake of liposomes
containing 5 mol% PEG and either 20 mol% anionic phosphatidylserine or 20 mol% cationic DODAC was equivalent to
uptake of neutral liposomes. In contrast to previous reports indicating that protein adsorption to liposomes increases uptake
by macrophages, the presence of bound serum protein did not increase the uptake of these liposomes by cultured
macrophages. Rather, we found that pre-incubating liposomes with serum reduced the uptake of liposomes containing
phosphatidylserine. Surprisingly, serum treatment of PEG-containing liposomes also significantly reduced liposome uptake
by macrophages. It is postulated that, in the case of phosphatidylserine liposomes, the bound serum protein can provide a
non-specific surface-shielding property that reduces the charge-mediated interactions between liposomes and bone marrow
macrophage cells. In addition, incubation of PEG-bearing liposomes with serum can result in a change in the properties of
the PEG, resulting in a surface that is better protected against interactions with cells. ß 2001 Elsevier Science B.V. All
rights reserved.
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1. Introduction
Macrophage particle uptake occurs by absorptive
endocytosis and strong binding of liposomes to cells
is a critical stage in the process [1^3]. Limiting the
degree of liposome^cell association should, therefore,
reduce mononuclear phagocytic system (MPS) up-
take. Adsorption may result from direct interaction
between the liposome and cell surface [2], or through
intermediary serum proteins, called opsonins [4]. Op-
sonin proteins adsorb to the surface of blood-born
particles such as bacteria, directing the particles to
the MPS for uptake. While a liposome-opsonizing
role has not been ¢rmly established for any speci¢c
protein in vivo [5], opsonization by puri¢ed serum
proteins is known to modify the interactions between
liposomes and cells in vitro [6] and is generally con-
sidered fundamental to liposome recognition by
phagocytic cells in vivo [5,7]. Thus liposome modi¢-
cations that reduce serum opsonization are predicted
to extend circulation longevity of liposomes. Con-
versely, it has also been suggested that long-circulat-
ing liposomes may interact with ‘dysopsonins’ [8],
serum proteins that can reduce liposome uptake.
To date, the most signi¢cant advance towards pro-
longing liposome circulation times has been achieved
through the inclusion of lipid polymers such as
monosialoganglioside (GM1) or poly(ethylene glycol)
(PEG)-grafted lipid [9^12]. PEG-derivatized phos-
phatidylethanolamine contains a long £exible hydro-
phobic polymer moiety attached to the amino group
of PE, a modi¢cation that converts the zwitterionic
PE to an anionic lipid with a grafted linear polymer.
It has been proposed that PEG can assume a ‘mush-
room’ or a ‘brush’ conformation [13] depending on
the PEG surface density on the liposome [11]. Exten-
sion of hydrophilic chains of PEG over the surface of
liposomes creates a ¢eld of hydration; the shape
and density of the hydrated ¢eld are dependent on
the orientation of PEG in space. For liposomes with
5 mol% PEG2000 the size of this barrier has been
estimated to be 5^6 nm [11,14,15]. This ¢xed aqueous
layer on the surface of PEG-containing liposomes
may either sterically interfere with interactions be-
tween cells and lipid headgroups or it may act as a
barrier to the binding of serum protein to the surface
of the liposomes [7,10,11,16].
There are many observations yet to be reconciled
with theoretical concepts of liposomal behavior in
the circulation. For instance, liposomes containing
PEG have extended circulation times [9,10], however
while PEG-lipids can reduce the rate of loss of lipo-
somes from the circulation, this occurs without alter-
ing the cumulative liposome uptake by the cells of
the MPS [5,10,11]. Another anomaly is that, unlike
conventional liposomes, MPS uptake of liposomes
containing PEG is less dependent on physicochemi-
cal factors such as charge, acyl chain saturation and
dose [12,17]. Interestingly, it has also been observed
that MPS blockade extends the circulation time of
PEG liposomes [18]. A related observation is that
PEG does not prevent MPS blockade induced by
liposome-encapsulated doxorubicin [19]. It is impor-
tant to note that PEG does not completely conceal
liposomes as proteins attached to PEG liposomes are
highly immunogenic [20,21]. Similar issues exist when
reconciling extended circulation times with the pro-
tective e¡ects of GM1 [18].
Clearly more information about interactions be-
tween liposomes, serum protein and macrophages is
required to develop an encompassing hypothesis for
behavior of liposomes in vivo. We have re-examined
the roles of charge, protein coating and a steric poly-
mer barrier on binding and uptake by macrophages
in culture. The macrophage target population used in
this study was mouse bone marrow cells. Bone mar-
row provides a readily accessible source of macro-
phage cells, without requiring proteolytic enzyme iso-
lation or chemical induction. Uptake of liposomes
into isolated bone marrow macrophage (BMM) cells
is inversely proportional to circulation longevity [22],
thus isolated macrophages can provide information
regarding uptake mechanisms in vivo. We have tried
to reconcile novel observations of macrophage up-
take of liposomes in vitro with circulation character-
istics of liposomes in vivo.
2. Materials and methods
2.1. Materials
Mouse serum was purchased from Cedarlane (Mis-
sissauga, Canada). Fetal bovine serum (FBS) was
purchased from Hyclone Laboratories (Logan, UT,
USA) and horse serum was obtained from (ICN
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Biomedicals Inc., Aurora, OH, USA), PFHMII (pro-
tein-free hybridoma medium) was purchased from
Gibco (Life Technologies, Burlington, Canada).
RPMI and Hank’s bu¡ered salt solution (HBSS)
were obtained from Stem cell technologies (Vancou-
ver, Canada). CHE ([3H]cholesteryl-hexadecyl ether)
was purchased from New England Nuclear Research
Products (Mississauga, Canada) (1 mCi/ml). Lip-
ids and 1,2-distearoyl-sn-glycero-3-phosphoethanol-
amine-m PEG2000 were purchased from Avanti Polar
Lipids (Birmingham, AL, USA), or Northern Lipids
(Vancouver, Canada). N,N-Dioleyl-N,N-dimethylam-
monium chloride (DODAC) was a generous gift
from Inex Pharmaceuticals (Vancouver, Canada).
Latex beads were obtained from Molecular Probes
(Eugene, OR, USA). All other chemicals were from
Sigma Chemical Co. (St. Louis, MO, USA).
2.2. Isolation of BMMs
Mouse BMMs were obtained by £ushing the fe-
mur bones of adult CD-1 mice with HBSS. Bone
marrow cells were collected by density gradient cen-
trifugation of this cell suspension. Cells were seeded
on non-tissue culture treated polystyrene plates in
HBSS. After 4 h, the HBSS and the non-attached
cells were removed and discarded. The macrophage
cells which remained were cultured for 5^7 days in a
2:1 mixture of macrophage media (RPMI containing
5% FBS, 5% horse serum) and L929 cell-conditioned
media. The cultured macrophages were s 95% viable
by trypan blue exclusion. For experiments, BMMs
were plated at 106 cells in 6 well tissue culture plates
(Falcon) 24 h before use. All uptake studies were
performed in PFHMII.
Uptake of latex beads was monitored as a means
of ensuring macrophage integrity under serum-free
conditions. Beads (100 nm £uorescent microspheres,
Molecular Probes) (107/well) were added to BMMs
in 6 well plates and incubated for up to 4 h and cells
at either 4‡C or 37‡C. BMMs were rinsed three times
with ice cold phosphate-bu¡ered saline (PBS), then
collected in PBS containing 0.2% sodium dodecyl
sulfate (SDS). Uptake was calculated by subtracting
the amount of cell-associated beads at 4‡C from the
amount of cell-associated beads at 37‡C. Fluores-
cence per bead was calibrated in order to quantify
bead uptake. PFHMII was identi¢ed as a protein-
free growth medium capable of maintaining BMMs
as a viable phagocytic population. All protein assays
were preformed using a micro bicinchoninic acid
(BCA) protein assay kit with BSA as standard
(Pierce, Rockford, IL, USA). Under our assay con-
ditions, 1 Wg of protein corresponds to approxi-
mately 1.3U104 macrophages.
2.3. Preparation of liposomes
Liposomes were prepared by aqueous reconstitu-
tion of dried lipid ¢lms in HEPES-bu¡ered saline
(10 mM HEPES (pH 7.4), 150 mM NaCl) [23].
[3H]CHE (0.08 Ci/mol) was added as radioactive
tracer. The sample was subjected to ¢ve freeze
thaw cycles prior to repeated high-pressure extrusion
through stacked 100 nm pore size polycarbonate
membrane ¢lters (Nuclepore, Pleasanton, CA,
USA) using an extruder purchased from Lipex Bio-
membranes (Vancouver, Canada). Liposome size was
determined by quasi-elastic light scattering using a
Nicomp submicron particle size analyzer. All lipo-
somes exhibited averaged diameters of 90^120 þ 25
nm.
2.4. Serum treatment of liposomes
Mouse serum was frozen and thawed no more
than two times to prevent inactivation of sensitive
proteins. 10 Wmol liposomes were incubated with
mouse serum (1:4 liposomes:serum, v/v) for 60 min
at 37‡C with gentle agitation. Separation of lipo-
somes from bulk serum protein was achieved by
passing liposomes over 12 ml Sepharose CL-4B
(Pharmacia, Uppsala, Sweden) gel ¢ltration column.
Fractions, 0.25 ml, were collected and aliquots were
assayed directly for the presence of protein and for
liposomes by scintillation counting. Liposome frac-
tions were pooled and used immediately for liposome
uptake studies or for analysis of associated protein.
The lipid-associated protein of each liposome frac-
tion was quanti¢ed following extraction of the lipid
with chloroform and methanol [24].
2.5. Proteins associated with liposomes
Protein extracted from column-recovered lipo-
somes was also analyzed by protein gel electropho-
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resis. Extracted proteins were analyzed by SDS^elec-
trophoresis on 7.5% polyacrylamide gels [25], devel-
oped with silver stain (Bio-Rad Silver Stain Plus Bio-
Rad Laboratories, Hercules, CA, USA).
2.6. Liposome uptake by tissue culture BMMs
Liposomes recovered from gel ¢ltration columns
were diluted to a ¢nal concentration of 1 mM total
lipid in PFHMII. For liposome uptake studies
BMMs were plated in 6 well tissue culture plates.
Tissue culture medium was removed from the wells
and cells were rinsed with HBSS then 2 ml of media
containing liposomes was added to each well. Unless
otherwise indicated, cells were incubated for 4 h at
37‡C in a humidi¢ed atmosphere. As a control for
liposome binding to cell surfaces, BMMs were incu-
bated on ice at 4‡C. BMMs were viable by trypan
blue exclusion after 4 h incubation at this temper-
ature. Medium was removed and wells were rinsed
twice with PBS then lysed in PBS containing 0.2%
SDS. Protein content was determined with the micro
BCA assay and liposome content was determined by
liquid scintillation counting in PicoFluor 40 (Canber-
ra Packard, Mississauga, Canada).
2.6.1. Statistics
Statistical analysis applied a two-tailed Student’s
t-test assuming unequal variances. Di¡erences with
P6 0.05 were considered signi¢cant. Data are pre-
sented as mean þ S.E.M.
3. Results
3.1. Macrophage bead uptake
We have re-examined PEG and the e¡ects of
bound serum proteins on liposome^phagocyte inter-
action in vitro with BMMs, a population of readily
accessible macrophage cells. Rather than simply
eliminate the serum from tissue culture media,
BMMs were cultured in protein-free media. To assess
the integrity of our cell preparation for monitoring
uptake of liposomes in the absence of serum, we ¢rst
ensured that the phagocytic capacity of macrophages
was intact and maintained during protein-free incu-
bation. To do this, the ability of the BMM prepara-
tions to phagocytose latex beads was assessed.
Phagocytosis of latex beads as a function of bead
to cell ratio in either RPMI media containing 10%
serum or in protein-free media is shown in Fig. 1. We
demonstrated that during protein-free culture the to-
tal uptake of beads at a ratio of 200 beads/cell was
reduced by 30% relative to cells cultured in 10% se-
rum, however cells did maintain vigorous phagocytic
activity. The reduction in bead uptake may be due to
the absence of serum factors that mark beads for
uptake (opsonins) or of serum factors that a¡ect
the macrophage cell directly. It is important to
note that serum factors are not obligatory for phag-
ocytic activity by the BMMs. Phagocytosis, mea-
sured by bead uptake, was linear with respect to
time and was temperature-dependent during pro-
tein-free culture (inset Fig. 1). The protein-free me-
dium in these studies supports the growth and main-
tains the phagocytic activity of BMMs. Thus the
Fig. 1. Phagocytosis of latex beads by cultured BMMs. One as-
sessment of the integrity of the macrophage preparation was re-
tention of macrophage phagocytic capacity determined by up-
take of £uorescent latex beads. Macrophage cells (2U106) were
incubated in 6 well Falcon plates with 1.1 WM latex beads for
2 h in the presence of serum (b) or protein-free medium
(PFHMII) (a). Cells were lysed and the uptake of beads was
determined by particle counting. The data presented are the
average mean of 2^10 replicates of triplicate experiments; bars,
S.E.M. Inset: temperature dependence of binding and uptake of
latex beads. Macrophages were seeded at 2U105 cells/well in
24 well plates and were incubated in PFHMII with 1U107 latex
beads/well at 37‡C (F) or at 4‡C (E). At indicated times the
cells were collected and the bead uptake per cell was deter-
mined. Data are averaged means from two triplicate experi-
ments; bars, S.E.M.
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e¡ect of protein bound to the liposomes could be
isolated from any direct e¡ects of serum factors on
these cells.
3.2. Separation of liposomes from bulk serum protein
and quanti¢cation of bound protein
To study the e¡ect of serum protein binding on
liposome uptake, liposomes were pre-exposed to se-
rum then recovered by gel ¢ltration. Certain serum
proteins strongly associate with liposomes, and thus
can be separated along with the liposomes from the
rest of the serum components by column chromatog-
raphy. The results of a typical chromatographic sep-
aration using a Sepharose CL-4B column are shown
in Fig. 2, where liposomes could be readily separated
from unbound protein. We could not achieve this
separation using the mini-spin column procedure de-
scribed by [6]. To limit the presence of unbound se-
rum protein, column fractions were pooled conserva-
tively, as indicated by the arrows.
Following recovery of liposomes from the gel ¢l-
tration column, lipid was extracted and the protein
residue was measured by the BCA assay to quantify
the amount of serum protein associated with lipo-
somes. The relative protein to lipid ratios for the
di¡erent liposome formulations studied are shown
in Table 1. For purpose of comparison, protein bind-
ing to 1,2-distearoyl-sn-glycero-3-phosphocholine
(DSPC)/cholesterol (Chol) liposomes (8.4 Wg pro-
tein/Wmol lipid) was compared to other liposomes
of di¡ering phospholipid acyl chain length, phospho-
lipid headgroup charge and presence of PEG. Protein
binding to 1,2-dimyristoyl-sn-glycero-3-phosphocho-
line (DMPC)/Chol liposomes (4.4 Wg protein/Wmol
lipid) or to DMPC/Chol/1,2-dioleoyl-sn-glycerol-3-
phosphoglycerol (PG) (5.4 Wg protein/Wmol lipid)
was not signi¢cantly di¡erent from protein binding
to DSPC/Chol liposomes or DSPC/Chol/PG, sug-
gesting that the acyl chain length was not a major
factor dictating protein binding. As expected, the de-
gree of serum protein binding was dependent on the
presence of charged lipids. Liposomes containing cer-
tain negatively charged phospholipids bound consid-
erably higher levels of protein than did the neutral
liposomes. Speci¢cally, DSPC/Chol/1,2-dioleoyl-sn-
glycerol-3-phosphoserine (PS) liposomes and DSPC/
Chol/cardiolipin liposomes bound two (P6 0.02) and
three (P6 0.005) times more protein, respectively,
than did DSPC/Chol liposomes. This increased se-
rum protein association, however, was not observed
with negatively charged PG-containing liposomes
(3.9 Wg protein/Wmol lipid). Importantly, the results
in Table 1 suggest that protein binding to liposomes
Fig. 2. Fractionation of serum-coated liposomes on CL-4B col-
umns. Liposomes were incubated in serum for 1 h before being
chromatographed on CL-4B Sepharose columns. Fractions of
0.25 ml were collected and assayed for relative protein content
by the micro BCA (see Section 2) assay or for liposome content
by scintillation counting. The lipid elution pro¢le (b) and the
protein elution pro¢le (no symbols) of DSPC:Chol (55:45) lipo-
somes is shown as an example of a typical chromatograph. The
lipid recovered was 88% of the total loaded onto the column.
The fractions between the arrows were pooled for macrophage
uptake studies.
Table 1
Protein binding as a function of liposome composition
Lipid composition Lipid mol
ratio
PB (Wg protein/
Wmol lipid)
DSPC:Chol 55:45 8.4 þ 1.8
Acyl chain length
DMPC:Chol 55:45 4.4 þ 1.3
Acyl chain length and charge
DMPC:Chol:PG 35:45:20 5.4 þ 3.1
Charge
DSPC:Chol:PS 35:45:20 20.2 þ 4.7
DSPC:Chol:cardiolipin 45:45:10 38.1 þ 7.1
DSPC:Chol:DODAC 35:45:20 11.3 þ 2.4
DSPC:Chol:PG 35:45:20 3.9 þ 1.7
5% PEG
DSPC:Chol:PEG 50:45:5 13.4 þ 3.4
DSPC:Chol:PS:PEG 30:45:20:5 15.2 þ 3.8
DSPC:Chol:DODAC:PEG 30:45:20:5 35 þ 5.5
Average of the means of 3^5 experiments þ S.E.M.
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was not decreased by incorporation of 5 mol% PEG.
For instance, the decrease in protein binding ob-
served with liposome containing both PS and PEG
(15.2 Wg protein/Wmol lipid) relative to PS liposomes
(20.0 Wg protein/Wmol lipid) was not statistically sig-
ni¢cant. Interestingly liposomes containing the cat-
ionic lipid DODAC formulated with 5 mol% PEG
bound signi¢cantly higher levels of associated protein
than corresponding DODAC liposomes without
PEG-modi¢ed lipids (P6 0.005). The serum binding
results show that incorporation of 5 mol% PEG-lip-
ids does not impede the ability of liposomes to inter-
act with serum proteins under the assay conditions
employed here. We were unable to demonstrate that
5 mol% PEG blocked binding of non-speci¢c serum
proteins to the surface of the liposomes as suggested
previously [14,26,27].
3.3. SDS^PAGE liposome-associated serum protein
While PEG does not alter the amount of protein
bound to the liposomes, it is possible that protein
binding pro¢les are altered for PEG liposomes pre-
pared with zwitterionic or charged phospholipids.
We analyzed the proteins extracted from serum-
treated liposomes by SDS^PAGE. The protein-band-
ing pattern obtained following analysis of six lipo-
some compositions is shown in Fig. 3 (lanes 2^7).
Consistent with the data in Table 1, the amount of
protein bound increased as the liposome composition
changed from neutral to anionic and cationic lipo-
some (lanes 2, 4, and 6, respectively). All major
bands can be attributed to protein in the serum pro-
tein samples seen in lane 1. We observed only minor
qualitative or quantitative di¡erences in liposome-as-
sociated protein as a function of PEG incorporation
for either the DSPC/Chol (lane 2 versus lane 3) or
DSPC/Chol/PS liposomes (lane 4 versus lane 5), con-
sistent with the results in Table 1. PEG did increase
the liposome-associated protein of DSPC/Chol/DO-
DAC liposomes (lane 7 versus lane 6). Some distinct
protein bands are observed on various liposome
compositions and are indicated with dots. One
band with a Mr in the range of 100 kDa appears
uniquely associated with PS liposomes, and bands
of Mr 104, 116, and 23.5 kDa appear only in the
PS liposomes with PEG. A protein of Mr 45 kDa
is apparent only on DODAC-containing liposomes
with PEG. Even in the presence of PEG, the lipo-
some composition, and most importantly the pres-
ence of charged lipid, determined the nature of inter-
actions with serum proteins.
3.4. E¡ect of bound serum factors on liposome uptake
by BMMs
Section 3.3 details recovery of liposomes from se-
rum with associated protein. To explore the interre-
lationship between PEG incorporation and serum
protein on liposome uptake by BMMs, we ¢rst
looked at the e¡ect of bound protein on uptake of
liposomes prepared without PEG. Liposome uptake
by macrophages was measured for selected liposome
formulations listed in Table 1. Protein-free liposomes
or liposomes with selectively bound proteins were
added to BMMs in protein-free media for 4 h and
cell uptake values for liposomes pre-incubated in se-
rum (shaded bars) or saline (¢lled bars) are shown in
Fig. 4A,B. In the absence of protein, liposomes
bound to, and were taken up by, BMMs. The
amount of liposome uptake by BMMs was depen-
dent on liposome composition. The lowest uptake
was observed for neutral liposomes, DSPC/Chol
Fig. 3. Protein was extracted from column-puri¢ed liposomes
(1 Wmol lipid) then separated on 7.5% acrylamide gels. Proteins
were visualized with silver stain. Lane 1 total mouse serum,
lane 2 DSPC:Chol, lane 3 DSPC:Chol:PEG, lane 4
DSPC:Chol:PS, lane 5 DSPC:Chol:PS:PEG, lane 6
DSPC:Chol:DODAC, lane 7 DSPC:Chol:DODAC:PEG. Mo-
lecular weight standards are indicated on the left.
BBAMEM 78068 13-6-01
S.A. Johnstone et al. / Biochimica et Biophysica Acta 1513 (2001) 25^3730
(55:45 mol/mol) and DMPC/Chol (55:45 mol/mol)
liposomes, with uptake values of 5.8 and 5.4 nmol/
mg cellular protein, respectively. Uptake was not in-
£uenced by acyl chain length, as uptake of DMPC/
Chol and corresponding DSPC-containing liposomes
was the same. High levels of uptake were observed
for liposomes containing the anionic lipids cardioli-
pin (139 nmol/mg cellular protein) and PS (161 nmol/
mg cellular protein). However, when liposomes were
prepared with 20 mol% PG, there was not a statisti-
cally signi¢cant increase in uptake over DSPC/Chol
or DMPC/Chol liposomes. The highest uptake was
observed with liposomes containing the cationic lip-
id, DODAC (301 nmol/mg cellular protein). The avid
uptake of cationic liposomes probably is not solely a
result of an elevated level of association with BMMs,
since the binding of PS liposomes and the binding of
DODAC liposomes to cells at 4‡C are not signi¢-
cantly di¡erent (data not shown).
Our results with serum-treated liposomes were un-
expected. In particular PS-containing liposomes were
taken up by macrophages less avidly following pro-
tein adsorption. The uptake of 20 nmol lipid/mg cel-
lular protein in the presence of bound serum protein
represents an 8-fold decrease relative to the uptake
measured in the absence of protein (P6 0.005). It is
worth noting that the uptake of protein bound PS
liposomes was still 2^3-fold higher than either the
DSPC/Chol liposomes or PG liposomes, with or
without bound serum protein. Uptake of either car-
diolipin or DODAC liposomes was not di¡erent
after serum treatment, thus associated protein had
no e¡ect on uptake of these liposomes. From these
results we conclude that serum protein is not re-
quired for liposome uptake, and the presence of pro-
tein does not determine the relative uptake of
charged or neutral liposomes. Nevertheless, our re-
sults are consistent with previous studies that have
shown that the liposomes that are taken up more
avidly by macrophages in vitro are the liposomes
that are eliminated more rapidly following intrave-
nous (i.v.) administration and bind greater levels of
serum protein in vitro.
3.5. E¡ect of bound serum protein on pegylated
liposome uptake by BMMs
BMM uptake was then measured for liposomes
containing PEG-grafted lipids (Fig. 5), in the pres-
ence (shaded bars) and absence (¢lled bars) of serum
protein, for neutral, anionic (PS) and cationic (DO-
DAC) liposomes. In the absence of protein, inclusion
of 5 mol% PEG reduced uptake of anionic PS-con-
taining or cationic DODAC-containing liposomes by
BMMs by 3-fold (P6 0.02) and 7-fold (P6 0.01),
respectively (compare Figs. 4 and 5). Thus our pro-
tein-free BMM model reproduces previous work
demonstrating inhibition of macrophage uptake of
liposomes with surface-associated PEG [22]. We ob-
served an increase in uptake of DSPC/Chol prepared
with 5 mol% PEG liposomes (50 nmol/mg cellular
protein) relative to the corresponding liposomes pre-
pared without PEG (5.8 nmol/mg cellular protein).
We showed in Table 1 that PEG did not inhibit
Fig. 4. E¡ect of serum coating on liposome uptake by macro-
phages. Liposomes were pre-incubated under serum-free condi-
tions (F) or pre-coated with mouse serum protein (l). The net
uptake of liposomes by macrophages was determined after 4 h
of incubation under serum-free conditions. Lipid compositions
of liposomes: DSPC:Chol (55:45), DMPC:Chol (55:45),
DSPC:Chol:PG (35:45:20), DMPC:Chol:PG (35:45:20),
DSPC:Chol:PS (35:45:20), DSPC:Chol:cardiolipin (35:45:20),
DSPC:Chol:DODAC (35:45:20). Average of the means of 3^5
triplicate experiments; bars, S.E.M.
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serum binding; yet serum treatment of PEG lipo-
somes signi¢cantly reduced BMM uptake of neutral,
anionic and cationic liposomes, by 10-fold
(P6 0.05), 8-fold (P6 0.01) and 3-fold (P6 0.05),
respectively (Fig. 5). The combined e¡ect of PEG
inclusion and serum treatment provided nearly com-
plete inhibition of liposome uptake for the neutral
and cationic liposomes. Similar to results obtained
for liposomes without bound protein, the levels of
cell association and liposome uptake were similar
for all PEG-containing formulations with bound se-
rum protein. This is interesting considering that the
amount of protein bound di¡ers signi¢cantly be-
tween these preparations (see Table 1).
Alterations in net liposome uptake by cultured
macrophages could be a consequence of changes ei-
ther in the binding step or in the internalization of
bound liposomes. In order to assess this, the uptake
data in Figs. 4 and 5 were replotted to show the
internalization of liposomes as a function of lipo-
some cell surface binding at 4‡C (Fig. 6). For each
composition we calculated the surface bound lipid as
a percent of the total cell-associated lipid. As shown
in Fig. 6A,B, after 4 h of incubation, the fraction of
liposomes without protein associated with the out-
side of the ranges from 25.2 to 68.7%. Liposome
composition fundamentally regulated the nature of
the e¡ect of serum. Reduced uptake of serum-treated
PS liposomes (Fig. 4B) corresponds to reduced mac-
rophage binding and thus the ratio of cell-associated
to surface bound PS is the same in the presence and
absence of associated serum proteins (Fig. 6A). The
ability of serum treatment to hinder the cell binding
step of PS liposome uptake argues for a dysopsonin
e¡ect of serum proteins. This e¡ect was not observed
Fig. 6. E¡ect of serum coating on the percent of associated lip-
id that represents liposomes incorporated into the cells. Lipo-
somes were pre-incubated under serum-free conditions (F) or
pre-coated with mouse serum protein (l). The fraction of in-
corporated liposomes by macrophages was determined by calcu-
lating the lipid uptake at 37‡C as a fraction of the total lipid
bound at 37‡C. Lipid compositions: A: DSPC:Chol (55:45),
DMPC:Chol (55:45), DSPC:Chol:PS (35:45:20), DSPC:Chol:
cardiolipin (35:45:20); B: DSPC:Chol:PG (35:45:20),
DMPC:Chol:PG (35:45:20), DSPC:Chol:DODAC (35:45:20);
C: DSPC:Chol:PEG (50:45:5), DSPC:Chol:PS:PEG (30:45:
20:5), DSPC:Chol:DODAC:PEG (30:45:20:5). Mean of two
or ¢ve triplicate experiments; bars, S.E.M.
Fig. 5. E¡ect of serum coating on uptake of liposomes contain-
ing PEG by macrophages. Liposomes generated with 5%
DSPE-PEG were pre-incubated under serum-free conditions (F)
or pre-coated with mouse serum protein (l). The net uptake of
liposomes by macrophages was determined after 4 h of incuba-
tion under serum-free conditions. Lipid compositions:
DSPC:Chol:PEG (50:45:5), DSPC:Chol:PS:PEG (30:45:20:5),
DSPC:Chol:DODAC:PEG (30:45:20:5). Average of the means
of 2^3 triplicate experiments; bars, S.E.M.
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with cardiolipin liposomes. Protein-free cardiolipin
liposomes surface association at 4‡C was higher in
comparison to the surface association of liposomes
with bound serum protein, resulting in a higher ratio
of internalized to cell bound lipid for the former case
(Fig. 6B).
The e¡ect of serum treatment of PEG liposomes
on the ratio of uptake was quite distinct (Fig. 6C).
Interestingly, serum treatment of PEG liposomes af-
fected both binding and internalization of cell-asso-
ciated lipid. The presence of bound serum protein on
PEG liposomes not only reduced the amount of sur-
face bound liposomes by 50^68% (Fig. 5) but also
reduced the uptake of cell-associated lipid to as little
as 10% of total cell-associated lipid (Fig. 6C). Similar
to data shown in Fig. 5, the percent of cell-associated
liposomes for formulations containing PEG was
comparable for neutral, anionic and cationic lipo-
somes suggesting the di¡erent compositions appear
similar to macrophages in culture.
4. Discussion
Our results contradict the assertion that high up-
take of anionic liposomes is a function of recognition
of bound serum proteins by macrophages and also
contradict the claim that PEG-grafted lipids reduce
macrophage uptake by reducing serum protein bind-
ing. First, we demonstrated that serum treatment
reduced uptake of only PS liposomes. Second, we
showed that serum reduces cell association of cardi-
olipin liposomes without altering uptake of these
liposomes. Third, we showed that in the presence
or absence of serum protein, neutral, anionic and
cationic liposomes with 5 mol% surface-grafted
PEG are taken up identically by cultured macro-
phages. PEG incorporation results in liposome sur-
faces that appear identical to macrophages, regard-
less of the charge of the lipid components. Thus, the
presence of PEG takes precedence over the presence
or absence of charged lipids for BMM uptake of
liposomes. Finally, the results strongly suggest that
serum protein binding to liposomes containing sur-
face-grafted PEG polymers provides a change in the
liposomal surface properties that reduces liposome
binding and uptake by BMMs. To reconcile these
¢ndings with the prevalent view that serum proteins
act as opsonins and govern liposome phagocytosis,
we have considered previous reports on the role of
protein binding in governing liposome uptake. Fur-
ther, we present a model that suggests that reduced
cell uptake of PEG liposomes is due, in part, to a
structural change in the grafted PEG polymer in-
duced by protein binding.
PEG-lipids tend to increase the circulation longev-
ity of i.v. injected liposomes [10,11,17,28]. PEG-lipid-
mediated reduction of uptake of liposomes by iso-
lated macrophages has been shown in most [29] but
not all studies [30]. The mechanism for these PEG
e¡ects has never been thoroughly explained, however
three possibilities have been suggested. PEG is postu-
lated to stabilize liposomes by preventing serum pro-
tein-mediated lipid degradation [11] or to obstruct
interactions between liposomes and cell surfaces
[9,10]. The most widely accepted theory, however,
is that the presence of PEG sterically hinders opsonin
protein binding [5]. Opsonins are best documented in
studies assessing the phagocytosis of bacteria. By
analogy to this process, immune and non-immune
opsonin proteins are hypothesized to adsorb non-
speci¢cally to liposome surfaces and in£uence uptake
by phagocytic cells [4] and accordingly, PEG inter-
feres with this process. Results presented here agree
with reports that macrophages and liposomes can
associate directly [2] and that liposome uptake does
not require opsonins [31]. PEG can interfere with this
interaction in the absence of protein, however pro-
teins bound to liposomes can enhance the ability of
PEG to interfere with cell association.
There is a signi¢cant body of circumstantial evi-
dence supporting the existence of opsonins capable
of in£uencing liposome uptake by macrophages and
perfused tissue. Liposomes have been shown to in-
teract with blood proteins [32,33] and rapid clearance
from the circulation was found to correlate with lipo-
some compositions having high serum protein bind-
ing [33]. Further, serum treatment of liposomes en-
hanced uptake of PS liposomes by perfused liver [34^
38]. There have also been in vitro studies suggesting
serum [2,39] or known bacterial opsonins, including
immunoglobulins, ¢bronectin, vitronectin and com-
plement increase the rates of uptake of liposomes
into cultured cells [5,6,40^47]. In addition, the
amount of complement bound in vitro [6] or L2 mac-
roglobulin bound in vivo [48] to various liposome
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preparations was found to be inversely proportional
to its circulation longevity. Support for an in vivo
role for complement in liposome clearance was
shown in a study demonstrating that K-76COOH,
a compound which interferes with complement acti-
vation, reduced liposome clearance in rats [49]. How-
ever results from other studies do not support the
opsonin hypothesis, suggesting either that there is
no serum requirement for liposome uptake, or
more interestingly, that dysopsonins can reduce lipo-
some uptake by macrophages. For instance, several
studies have observed that serum either decreased
liposome uptake [38,50,51] or did not alter liposome
uptake [52] by perfused liver. Ahl et al. [46] reported
that, for two di¡ering liposome preparations, the
level of complement binding did not correlate with
circulation times.
Despite the mixed evidence presented above for
opsonization of liposomes, the theory that PEG-lip-
ids extend liposome circulation lifetime by preventing
opsonins from binding to liposomes is a reasonable
and attractive proposal. This theory is supported by
the demonstration that PEG-lipids reduced liposome
partitioning in an aqueous/PEG two-phase system
[53]. In addition, protein binding to a PEG mono-
layer decreased with increasing PEG concentration
[54]. Protein^liposome interactions as measured by
complement activation [4,47,51] or biotin binding
to liposome-associated avidin [15] were shown to be
decreased on liposomes containing PEG-lipids sug-
gesting PEG can block protein interactions with sub-
stances on liposome surfaces. A recent study showed
that a minimum of 10^15 mol% (N-monoethoxy
poly(ethylene glycol) succinyl)1,2-distearoyl-sn-glyc-
ero-3-phosphoethanolamine Mr 2000 (DSPE-PEG
2000) was required to prevent PS liposome activation
of the prothrombinase complex [55]. Importantly,
5 mol% DSPE-PEG, a quantity su⁄cient to prolong
circulation [56], was not su⁄cient to prevent this
binding. This implies that higher concentrations of
PEG may be required to fully block interactions be-
tween liposomes and proteins than to block uptake.
In fact, Harvie et al. [57] noted that liposomes, pre-
pared without PEG or with approximately 10 mol%
PEG, had identical bound protein levels when iso-
lated from mice 30 min post-injection. In addition,
cell uptake of PC liposomes pre-exposed to whole
plasma was the same when prepared with or without
10 mol% PEG [58].
A recent report identi¢es a receptor on phagocytic
cells which recognizes PS exposed on the plasma
membrane of apoptotic cells. Importantly, target
cell recognition by this receptor can be blocked by
PS liposomes [59]. Further, in accordance with the
present study, Kamps [60] showed that uptake of PS-
containing liposomes by rat liver macrophage and
endothelial cells in vitro was inhibited by serum in
a manner that was dependent on the cell type and the
source of sera. Liposome uptake by various cell pop-
ulations in vitro allied more closely with liposome
distribution in vivo when the incubations were
made in the presence of serum. This provided the
basis for a suggestion of speci¢c and non-speci¢c
uptake mechanisms for PS. This suggests that inhi-
bition of liposomes uptake by serum protein, ob-
served here with BMMs, may be relevant for regu-
lating tissue uptake in vivo, for instance limiting
uptake in the RES tissues observed by Woodle [61].
We suggest protein associated with the liposome may
limit recognition of PS liposomes by speci¢c or non-
speci¢c cell receptors (see Fig. 7A). The hindrance of
liposome uptake by protein may be through an in-
crease in the hydrophilicity of liposomes, thereby
limiting interactions with cell membranes or cell pro-
teins. Alternatively, the serum protein may sterically
hinder interaction between PS and the cell mem-
brane. While we observed that mouse serum protein
reduced uptake of PS liposomes, BMM uptake of all
liposomes with or without serum was still propor-
tional to expected plasma elimination rates of lipo-
somes without surface-grafted PEGs.
Serum not only has speci¢c e¡ects on PS liposome
uptake, but also lipid composition-dependent e¡ects
on liposome cell association. Serum treatment re-
duced cell association of cardiolipin liposomes with-
out altering cell uptake. While liposome charge is
known to be important, but not determinant, this
result suggests that cell surface association is also
insu⁄cient to promote uptake by macrophages.
This observation could be accounted for by the exis-
tence of productive surface association, characterized
as liposome binding to the cells which leads to up-
take, and non-productive surface association which
does not lead to uptake. Thus, in contrast to results
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observed with PS, in the case of cardiolipin protein
association only inhibits non-productive binding.
An important conclusion of this paper is that PEG
does not prevent interactions with serum proteins.
PEG is thought to form a shroud on the surface of
the liposomes partially shielding hydrostatic charges
[27], however this may still allow for protein inter-
actions with the surface of the liposome. Perhaps
even more controversial, PEG itself may provide a
sca¡olding onto which protein can bind. We propose
that serum proteins and PEG act together to in£u-
ence liposome^macrophage cell association. This ad-
ditive e¡ect may be a consequence of a change in the
conformation of the surface-grafted PEG. For in-
stance PEG incorporated to 5 mol% may be in the
mushroom conformation. Following protein binding,
steric constraints imposed on the PEG may result in
a change in the conformation to the brush confor-
mation (see Fig. 7B). The increased extension of the
PEG brought about by this conformational change is
thus more e¡ective at preventing association and up-
take of liposomes by macrophages.
It is worth noting that the combined e¡ect of PEG
and serum protein is reminiscent to observations
made with polymer-coated nanoparticles and serum
proteins. Hydrophobic latex particles share some
properties with liposomes, including being avidly
taken up by macrophages. Like liposomes, macro-
phage uptake of nanoparticles increases with size
and surface charge [62]. Nanoparticles coated with
hydrophilic PEG-like materials such as poloxamine-
908 [63] have prolonged circulation in vivo and mac-
rophage uptake of particles in vitro decreases with
increased thickness of the polymer coating [64]. Se-
rum enhances the e¡ect of polymer coating, further
reducing particle uptake by isolated macrophages,
suggesting that a combined e¡ect of hydrophobicity,
opsonization and dysopsonization determines uptake
Fig. 7. Models for serum protein regulation of liposome^macrophage interactions. A: Serum inhibition of PS liposome uptake. Under
serum-free conditions, liposomal PS interacts with macrophage membranes, possibly via a PS-speci¢c receptor. Serum protein interac-
tion with the liposomal surface reduces interaction with cell membranes. Both a speci¢c recognition of PS by dysopsonins (arrows) or
a steric hindrance by bulk protein interactions are consistent with this inhibition. B: Serum inhibition of uptake of liposomes contain-
ing PEG. In the absence of serum, PEG reduces the uptake of liposomes containing charged lipids, however it does not completely
block uptake, suggesting the surface of the liposome is accessible. This may be due to PEG being in the mushroom con¢guration,
however allowing for protein and cell surface interactions. Hydrostatic interactions between PEG and serum protein induce the PEG
to adopt a more extended con¢guration, preventing uptake by phagocytic cells.
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of coated particles by macrophages [63]. In an anal-
ogous fashion, we suggest that it is the combination
of PEG and serum, altering the overall hydrophobic-
ity of liposomes, which determines macrophage up-
take.
Understanding macrophage^liposome interactions
is critical to developing long-circulating liposome
preparations. Modi¢cation of the liposome physio-
chemistry alters circulation longevity and engenders
corresponding changes in macrophage uptake in vi-
tro. We have concluded that PEG liposomes can
bind to macrophages and be internalized. Further,
PEG does not a priori need to reduce interaction
between serum proteins and liposomes in order to
provide its steric stabilization e¡ects. We suggest
that the primary e¡ect of surface-grafted PEG poly-
mers is to reduce cell uptake of liposomes and that
the liposome bound proteins play a role by a¡ecting
the PEG conformation.
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